Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 325 clinical trials
Long-term Non-interventional Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy

Subjects who previously took part in the FT500-101 study and received allogeneic NK cell immunotherapy will take part in this long term follow-up study. Subjects will automatically enroll into study FT-003 once they have withdrawn or complete the parent interventional study. The purpose of this study is to provide long-term …

  • 0 views
  • 23 Jan, 2021
  • 3 locations
Appropriate Dosing to Optimise Personalised Cancer Treatments

This is a pilot study to assess feasibility of dried blood spot (DBS) samples for pharmacokinetic measurements of targeted anti-cancer drugs in oncology patients such as patients with BRAF-mutant melanoma receiving targeted treatment with BRAF and MEK inhibitors.

ovarian carcinoma
lung carcinoma
BRAF
KIT
ovarian epithelial carcinoma
  • 0 views
  • 25 Jan, 2021
  • 1 location
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes

This study examines at-home monitoring of patient-generated phsyiologic health data and patient-reported outcomes. Patient-generated health data using at-home monitoring devices and smart device applications are used more and more to measure value and quality in cancer care. This trial may show whether at-home monitoring programs can improve the care of …

cancer
cancer treatment
primary cancer
cancer care
  • 0 views
  • 25 Jan, 2021
  • 1 location
Monitoring the Diagnosis and Management of Acute Leukaemia In Pregnancy Study.

Acute leukaemia (AL) is an aggressive but potentially curable cancer that can affect women of childbearing age. When a pregnancy is complicated by a diagnosis of AL, clinicians face a complex dilemma: to balance risking the mother's survival through delaying treatment, against the potential harm to the foetus through exposure …

cancer
myelodysplasia
  • 0 views
  • 21 Mar, 2021
  • 1 location
WGA in Platinum-refractory HNSCC Underwent Nivolumab

To choose a subgroup who could clearly benefit from Nivolumab, we are proposing a prospective observational study. Whole-genome study (WGS) analysis will be performed on archived cancer tissues from patients who were (1) cisplatin-refractory and subsequently (2) received Nivolumab (at least 4 doses) and (3) had completed imaging response evaluation …

cancer
nivolumab
  • 1 views
  • 22 Jan, 2021
  • 1 location